Please find enclosed Investor Presentation for the quarter ended June 30 2026

AI summary - Consolidated Q1FY27 sales grew 10% y-y to ₹2,852 Cr; EBITDA declined 9% y-y to ₹255 Cr; PAT down 14% y-y to ₹128 Cr - Animal Nutrition India volumes up 15%, underlying segment margin improved to 7.8% from 6.5% y-y - Oil Palm segment revenue rose 29%, EBIT up 14%, driven by better realizations and extraction efficiency - Crop Care revenue down 17%, margin contracted due to delayed monsoon and lower volumes - Astec LifeSciences reduced losses, EBITDA break-even continued - Creamline Dairy revenue up 11%, EBITDA margin declined to 1.5% due to higher milk prices - Godrej Foods stable revenue, EBITDA margin down on input cost inflation - ACI Godrej Bangladesh sales volume +14.5%, PBT +12% in local currency - Net working capital days improved to 665 from 878 y-y, aiding ROCE - Capex guidance maintained at ₹300-350 Cr/year, focused on high-margin businesses